.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Harvard Business School
Farmers Insurance
Deloitte
McKinsey
QuintilesIMS
Citi
Dow
Fuji
Express Scripts

Generated: September 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074904

« Back to Dashboard
NDA 074904 describes TOPICORT, which is a drug marketed by Taro and is included in ten NDAs. It is available from three suppliers. There are three patents protecting this drug and one Paragraph IV challenge. Additional details are available on the TOPICORT profile page.

The generic ingredient in TOPICORT is desoximetasone. There are seven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the desoximetasone profile page.

Summary for NDA: 074904

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)

Pharmacology for NDA: 074904

Suppliers and Packaging for NDA: 074904

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TOPICORT
desoximetasone
GEL;TOPICAL 074904 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-1261 51672-1261-1 1 TUBE in 1 CARTON (51672-1261-1) > 15 g in 1 TUBE
TOPICORT
desoximetasone
GEL;TOPICAL 074904 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-1261 51672-1261-2 1 TUBE in 1 CARTON (51672-1261-2) > 30 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;TOPICALStrength0.05%
Approval Date:Jul 14, 1998TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
McKinsey
Cerilliant
Accenture
US Army
Healthtrust
Mallinckrodt
Johnson and Johnson
Cipla
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot